Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Cavotec - Short-term caution clouding momentum

15 oktober 2025

<a id="bm-comp-69fe94ce-df51-455b-9674-4239aea6e477" name="bm-comp-69fe94ce-df51-455b-9674-4239aea6e477" class="BMCustomAnchor"></a><table><tr><td bm-component-id="69fe94ce-df51-455b-9674-4239aea6e477" style="vertical-align: top; width:100.000000%;"><ul><li>Report out on 7 November</li><li>Q3e sales of EUR 40m (44m), EBIT EUR 2.3m (3m)</li><li>Customer hesitancy likely to persist in the near-term</li></ul></td></tr></table><a id="bm-comp-1a2fe0aa-7fe3-435b-84ae-87f8f4dbb3e5" name="bm-comp-1a2fe0aa-7fe3-435b-84ae-87f8f4dbb3e5" class="BMCustomAnchor"></a><table><tr><td bm-component-id="1a2fe0aa-7fe3-435b-84ae-87f8f4dbb3e5" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q3 expectations</h3><p style="text-align:left;">For Q3 we estimate sales of EUR 40m (-10% y-o-y, +11% q-o-q) and order intake of EUR 38m (+5% y-o-y). We expect the customer caution observed in Q2 due to ongoing global uncertainty to continue to weigh on Cavotec in the near term. We expect this to primarily affect Cavotec&#8217;s products and services with shorter lead times, which we expect will result in softer sales in the quarter. For P&amp;M, we estimate sales of EUR 24m (-13% y-o-y) and for Industry, sales of EUR 15m (-6% y-o-y). Moreover, we expect Cavotec to continue facing slightly elevated costs, primarily related to the large shore power orders placed in Q4'24, which we anticipate will be delivered mainly in Q4'25e and early 2026e. As deliveries tied to these orders progress, we expect sales momentum to strengthen towards the end of 2025e. On EBIT, we estimate EUR 2.3m (3m) for a margin of 5.8% (6.8%).</p><h3 class="bm-h3">Estimate changes and outlook</h3><p>We lower '25e-'27e sales by 3-1% and total '25e-'27e EBIT by EUR 4m, as we take a more cautious view on both near-term demand, given customer hesitancy, and the expected trajectory of profitability improvement. However, we continue to believe that shore power orders should gather pace due to regulatory drivers. This month, the company announced orders worth a total of EUR 9.4m for shore power systems, corresponding to ~7% of the Group's Q2'25 backlog and ~2% of cumulative '25e-'27e sales.</p><h3 class="bm-h3">Long-term view unchanged</h3><p>While our positive view of Cavotec's long-term outlook remains unchanged, we believe the company&#8217;s near-term focus will be on driving volume growth, which we consider essential for the company to reach its financial targets. The share is trading at 25x-11x EV/EBIT in '25e-'27e vs. peers at 17x-11x.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-14 Skolon - Timing effects to weigh on Q2 Skolon Analys
2026-08-14 NYAB - Delivering on its promises NYAB Analys
2026-08-14 BTS Group - Organic growth beat and raised guidance BTS Group Analys
2026-08-13 NYAB - Strong earnings beat, +27% vs cons NYAB Analys
2026-08-12 G5 Entertainment - Cost cuts to support earnings ... G5 Entertai.. Analys
2026-08-12 Ferronordic - Three for three Ferronordic Analys
2026-08-12 G5 Entertainment - Larger cost savings offsetting... G5 Entertai.. Analys
2026-08-12 Ferronordic - Earnings beat across the board Ferronordic Analys
2026-08-11 OssDsign - Waiting for the growth to return OssDsign Analys
2026-08-11 Arctic Paper - Pulp beats paper II Arctic Paper Analys
2026-08-11 Generic - The growth journey continues Generic Analys
2026-08-10 Donkey Republic - Q2 likely to confirm strong gro... Donkey Repu.. Analys
2026-08-06 Medicover - Divests Medicover Hospitals India Medicover Analys
2026-07-30 Byggmästaren - Private assets strong, but Green s... Byggmästaren Analys
2026-07-30 Catella - Recovery gradually taking shape Catella Analys
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys